Alkaline Phosphatase and Mortality in Patients on Peritoneal Dialysis

Abstract

Background and objectives Elevated total serum alkaline phosphatase levels have been associated with higher mortality in the general population, CKD patients, and hemodialysis patients. However, in peritoneal dialysis patients, this association has received little attention. The aim of this study was to evaluate the association between alkaline phosphatase and all-cause and cardiovascular mortality in peritoneal dialysis patients.Design, setting, participants, & measurements In this single center retrospective cohort study, 1021 incident peritoneal dialysis patients from January 1, 2006, to December 31, 2010 with baseline serum alkaline phosphatase values were enrolled. Collected baseline data included demographic characteristics and clinical and laboratory measurements. All patients were followed until December 31, 2012. The associations of total serum alkaline phosphatase levels with allcause and cardiovascular mortality were assessed using multivariable-adjusted Cox models.Results Of 1021 patients, mean age was 47.5 (615.5) years, 59.1% of patients were men, and 22.8% of patients were diabetic. The median serum alkaline phosphatase level was 64 U/L (interquartile range=52-82 U/L). During a median 31-month (interquartile range=19-45 months) follow-up period, 203 patients died, of which 109 deaths were caused by cardiovascular disease. After adjusting for demographics, comorbid conditions, liver function, and bone metabolism parameters, the highest alkaline phosphatase quartile was significantly associated with a hazard ratio for all-cause mortality of 1.70 (95% confidence interval, 1.06 to 2.74, P=0.03) and a hazard ratio for cardiovascular mortality of 1.94 (95% confidence interval, 1.02 to 3.72, P=0.04). Each 10 U/L higher baseline alkaline phosphatase level was associated with 4% (95% confidence interval, 1.00 to 1.08, P=0.04) and 7% (95% confidence interval, 1.02 to 1.11, P=0.003) higher risk of all-cause and cardiovascular mortality, respectively. ConclusionHigher total serum alkaline phosphatase levels at the commencement of peritoneal dialysis were independently associated with all-cause and cardiovascular mortality in peritoneal dialysis patients.

Does pth offer Additive Value to Alp Measurement in Assessing Ckd-Mbd?

“…Of particular note, increased PTH concentration did not predict mortality unless ALP activity was also increased. The data resonate with that recently published from other PD populations in China (37) and amongst black Americans (38).…”

High Neutrophil-to-Lymphocyte Ratio is a Significant Predictor of Cardiovascular and All-Cause Mortality in Patients Undergoing Peritoneal Dialysis

“…The primary endpoints were cardiovascular mortality and all-cause mortality. Cardiovascular death included death caused by coronary events, arrhythmias, sudden cardiac death, congestive heart failure, and cerebrovascular events [13]. The study was performed according to the Declaration of Helsinki and approved by the ethics committee of Beijing Chao-Yang Hospital, Capital Medical University.…”

Association between red cell distribution width and mortality in patients undergoing continuous ambulatory peritoneal dialysis

“…Despite an increased understanding of pathophysiological processes in patients undergoing PD and subsequent improvements in management strategies, the mortality rate associated with PD is still high. The leading cause of mortality is cardiovascular disease (CVD), accounting for 40–50% of all deaths2.…”